Literature DB >> 27698875

Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance.

Hao Gu1, Xin-Yu Wu2, Rui-Tai Fan1, Xin Wang1, You-Zhong Guo1, Rui Wang1.   

Abstract

The side population (SP) assay is a widely used method for isolating stem cell-like cells from cancer cell lines and primary cells. The cancer cells used in different laboratories have been passaged for different generations. Emerging evidence revealed that repeated passaging of cell lines for multiple generations frequently leads to change of characteristics. Thus, it is worth investigating the effects of repeated passaging on the biological and functional properties of the enriched SP fraction from early- and late-passage cells. The present study reports that the cancer stem cell (CSC) characteristics, including increased frequency of tumor-initiating and self-renewal capacity, and resistance to the chemotherapy agent doxorubicin and ionizing radiation, was diminished in SP cells from late-passage non-small cell lung cancer (NSCLC) cells. This finding revealed that the SP from long-term passage NSCLC cells was not consistently enriched for stem cell-like cancer cells, and low-passage cell lines and primary cancer cells are therefore recommended in the CSCs field.

Entities:  

Keywords:  cancer stem cell; early passage; late passage; resistance; side population; tumorigenicity

Year:  2016        PMID: 27698875      PMCID: PMC5038156          DOI: 10.3892/ol.2016.4934

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

Review 1.  Radiation-induced apoptosis.

Authors:  M Verheij; H Bartelink
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

Review 6.  Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.

Authors:  Frank Pajonk; Erina Vlashi; William H McBride
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

Review 7.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

Review 8.  Cancer stem cells in solid tumors.

Authors:  Laurie E Ailles; Irving L Weissman
Journal:  Curr Opin Biotechnol       Date:  2007-10       Impact factor: 9.740

9.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Identification and expansion of the tumorigenic lung cancer stem cell population.

Authors:  A Eramo; F Lotti; G Sette; E Pilozzi; M Biffoni; A Di Virgilio; C Conticello; L Ruco; C Peschle; R De Maria
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

View more
  3 in total

1.  miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.

Authors:  Yu-Shui Ma; Fei Yu; Xiao-Ming Zhong; Gai-Xia Lu; Xian-Ling Cong; Shao-Bo Xue; Wen-Ting Xie; Li-Kun Hou; Li-Juan Pang; Wei Wu; Wei Zhang; Le-Le Cong; Tie Liu; Hui-Deng Long; Ran Sun; Hong-Yan Sun; Zhong-Wei Lv; Chun-Yan Wu; Da Fu
Journal:  Mol Ther       Date:  2018-09-13       Impact factor: 11.454

2.  Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer.

Authors:  Kamal Shaik Fakiruddin; Moon Nian Lim; Norshariza Nordin; Rozita Rosli; Zubaidah Zakaria; Syahril Abdullah
Journal:  Cancers (Basel)       Date:  2019-08-28       Impact factor: 6.639

3.  Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells.

Authors:  Jan Jakub Lica; Miłosz Wieczór; Grzegorz Jan Grabe; Mateusz Heldt; Marta Jancz; Majus Misiak; Katarzyna Gucwa; Wioletta Brankiewicz; Natalia Maciejewska; Anna Stupak; Maciej Bagiński; Krzysztof Rolka; Andrzej Hellmann; Andrzej Składanowski
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.